Back to Search
ALI AWADA, PHARMD
PHARMD
Pharmacist
NPI: 1285315051Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
5302415342(MI)
Research & Publications (20)
An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer.
PMID 19633042·Ann Oncol·2010
3-trial
[Deep non-reactive reversible coma after a Mediterranean neurotoxic fish poisoning].
PMID 19665158·Rev Neurol (Paris)·2010
5-case
Pemetrexed combined with paclitaxel: a dose-finding study evaluating three schedules in solid tumors.
PMID 18956139·Invest New Drugs·2009
3-trial
Hypoxia-inducible factor in cancer angiogenesis: structure, regulation and clinical perspectives.
PMID 19186072·Crit Rev Oncol Hematol·2009
6-review
[Therapeutic consequences of molecular biology advances in oncology].
PMID 19211361·Bull Cancer·2009
6-review
Lapatinib monotherapy in patients with HER2-overexpressing relapsed or refractory inflammatory breast cancer: final results and survival of the expanded HER2+ cohort in EGF103009, a phase II study.
PMID 19394894·Lancet Oncol·2009
3-trial
The medical treatment of metastatic renal cell cancer in the elderly: position paper of a SIOG Taskforce.
PMID 18774306·Crit Rev Oncol Hematol·2009
1-meta
Evaluation of the prognostic significance of serum galectin-3 in American Joint Committee on Cancer stage III and stage IV melanoma patients.
PMID 19581819·Melanoma Res·2009
8-other
Phase I dose escalation study of weekly ixabepilone, an epothilone analog, in patients with advanced solid tumors who have failed standard therapy.
PMID 18446338·Cancer Chemother Pharmacol·2009
3-trial
Should the indications for the use of myeloid growth factors for the prevention of febrile neutropenia in cancer patients be extended?
PMID 19509500·Curr Opin Oncol·2009
6-review
Changing the clinical picture of challenging tumors: tales becoming reality?
PMID 19663729·Future Oncol·2009
6-review
Mechanistic population pharmacokinetics of total and unbound paclitaxel for a new nanodroplet formulation versus Taxol in cancer patients.
PMID 18791718·Cancer Chemother Pharmacol·2009
4-observational
Multiple-pool cell lifespan models for neutropenia to assess the population pharmacodynamics of unbound paclitaxel from two formulations in cancer patients.
PMID 18791717·Cancer Chemother Pharmacol·2009
4-observational
[Spasmodic laughter syncope. An unusual complication of pseudobulbar palsy].
PMID 18808775·Rev Neurol (Paris)·2009
5-case
Head and neck cancer emerging strategies: advances and new challenges.
PMID 19346942·Curr Opin Oncol·2009
8-other
Phase II study on gemcitabine in recurrent and/or metastatic adenoid cystic carcinoma of the head and neck (EORTC 24982).
PMID 18819792·Eur J Cancer·2008
3-trial
[Brucellar meningitis complicated by aneurysmal subarachnoid hemorrhage].
PMID 18808777·Rev Neurol (Paris)·2008
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3255 OWEN RD
FENTON, MI 48430 - Phone
- (810) 714-2406
Quick Facts
- NPI
- 1285315051
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile